{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:38:57Z","timestamp":1776944337354,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijcard.2022.09.066","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T04:42:23Z","timestamp":1664426543000},"page":"92-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens"],"prefix":"10.1016","volume":"371","author":[{"given":"Luigi","family":"Vignali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Luca","family":"Gurgoglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Barocelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Alberta","family":"Cattabiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Solinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Maini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Tadonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Benatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Pel\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Coli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ardissino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Niccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2022.09.066_bb0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.09.066_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2022.09.066_bb0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2022.09.066_bb0020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term casecontrol study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2022.09.066_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.09.066_bb0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"9921","key":"10.1016\/j.ijcard.2022.09.066_bb0035","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.ijcard.2022.09.066_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00228-016-2152-8","article-title":"Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation-a cohort study in primary care","volume":"73","author":"W\u00e4ndell","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.ijcard.2022.09.066_bb0045","article-title":"Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature","volume":"2","author":"Long","year":"2019","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.09.066_bb0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/STROKEAHA.118.023368","article-title":"Cortical superficial siderosis evolution","volume":"50","author":"Charidimou","year":"2019","journal-title":"Stroke."},{"issue":"13","key":"10.1016\/j.ijcard.2022.09.066_bb0055","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention."},{"issue":"17","key":"10.1016\/j.ijcard.2022.09.066_bb0060","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4244\/EIJV14I17A293","article-title":"Indications, current adoption and future perspectives for percutaneous left atrial appendage closure","volume":"14","author":"Fukutomi","year":"2019","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.ijcard.2022.09.066_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5273(96)02862-8","article-title":"Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation","volume":"58","author":"Tsai","year":"1997","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.09.066_bb0070","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mhj.2003.91","article-title":"Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation","volume":"145","author":"Stoddard","year":"2003","journal-title":"Am. Heart J."},{"issue":"19","key":"10.1016\/j.ijcard.2022.09.066_bb0075","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"PROTECT AF Steering Committee and Investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.ijcard.2022.09.066_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2022.09.066_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"13","key":"10.1016\/j.ijcard.2022.09.066_bb0090","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4244\/EIJV11I13A292","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention."},{"issue":"30","key":"10.1016\/j.ijcard.2022.09.066_bb0095","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the AmplatzerTM AmuletTM device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.ijcard.2022.09.066_bb0100","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"PRAGUE-17 Trial Investigators. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2022.09.066_bb0105","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2022.09.066_bb0110","first-page":"245","article-title":"Occurrence of incomplete endothelialization causing residual permeability after left atrial appendage closure","volume":"30","author":"Granier","year":"2018","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ijcard.2022.09.066_bb0115","article-title":"Comorbidity burden in patients undergoing left atrial appendage closure","author":"Sanjoy","year":"2020","journal-title":"Heart."},{"issue":"25","key":"10.1016\/j.ijcard.2022.09.066_bb0120","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.ijcard.2022.09.066_bb0125","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention."},{"issue":"9","key":"10.1016\/j.ijcard.2022.09.066_bb0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14779072.2018.1510316","article-title":"Antithrombotic strategies after interventional left atrial appendage closure: an update","volume":"16","author":"Chen","year":"2018","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"18","key":"10.1016\/j.ijcard.2022.09.066_bb0135","doi-asserted-by":"crossref","first-page":"e2138","DOI":"10.4244\/EIJ-D-17-00901","article-title":"Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices","volume":"13","author":"Weise","year":"2018","journal-title":"EuroIntervention."},{"issue":"2","key":"10.1016\/j.ijcard.2022.09.066_bb0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5603\/KP.a2017.0245","article-title":"Dual antiplatelet therapy is safe and efficient after left atrial appendage closure","volume":"76","author":"Maksym","year":"2018","journal-title":"Kardiol. Pol."},{"issue":"12","key":"10.1016\/j.ijcard.2022.09.066_bb0145","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.amjcard.2019.08.050","article-title":"Effectiveness of only aspirin or clopidogrel following percutaneous left atrial appendage closure","volume":"124","author":"Pouru","year":"2019","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2022.09.066_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00015385.2018.1455946","article-title":"Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug","volume":"74","author":"Bertrand","year":"2019","journal-title":"Acta Cardiol."},{"issue":"134","key":"10.1016\/j.ijcard.2022.09.066_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2020.08.013","article-title":"Safety and efficacy of single versus dual antiplatelet therapy after left atrial appendage occlusion","author":"Patti","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2022.09.066_bb0160","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/jcm10091959","article-title":"Role of different antithrombotic regimens after percutaneous left atrial appendage occlusion: a large single center experience","volume":"10","author":"Mazzone","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2022.09.066_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest."},{"issue":"5","key":"10.1016\/j.ijcard.2022.09.066_bb0170","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest."},{"issue":"1","key":"10.1016\/j.ijcard.2022.09.066_bb0175","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace."},{"issue":"5","key":"10.1016\/j.ijcard.2022.09.066_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"23","key":"10.1016\/j.ijcard.2022.09.066_bb0185","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.ijcard.2022.09.066_bb0190","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"Standardized data collection for cardiovascular trials initiative (SCTI). 2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.ijcard.2022.09.066_bb0195","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.STR.0000027437.22450.BD","article-title":"Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale","volume":"33","author":"Wilson","year":"2002","journal-title":"Stroke."},{"issue":"16","key":"10.1016\/j.ijcard.2022.09.066_bb0200","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","article-title":"Antithrombotic therapy in patients undergoing transcatheter interventions for structural heart disease","volume":"144","author":"Calabr\u00f2","year":"2021","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.ijcard.2022.09.066_bb0205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcin.2013.02.014","article-title":"Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion","volume":"6","author":"Plicht","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"issue":"11","key":"10.1016\/j.ijcard.2022.09.066_bb0210","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/heartjnl-2014-306332","article-title":"Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure","volume":"101","author":"L\u00f3pez M\u00ednguez","year":"2015","journal-title":"Heart."},{"issue":"3","key":"10.1016\/j.ijcard.2022.09.066_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005997","article-title":"Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy","volume":"11","author":"Pracon","year":"2018","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"2","key":"10.1016\/j.ijcard.2022.09.066_bb0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/joic.12502","article-title":"An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion","volume":"31","author":"Yerasi","year":"2018","journal-title":"J. Interv. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2022.09.066_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1253\/circj.CJ-20-0373","article-title":"Impact of frailty on bleeding events related to anticoagulation therapy in patients with atrial fibrillation","volume":"85","author":"Ohta","year":"2021","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2022.09.066_bb0230","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/CIA.S159373","article-title":"Hospitalized frail elderly patients - atrial fibrillation, anticoagulation and 12 months\u2019 outcomes","volume":"13","author":"Ekerstad","year":"2018","journal-title":"Clin. Interv. Aging"},{"issue":"8","key":"10.1016\/j.ijcard.2022.09.066_bb0235","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jcin.2010.04.017","article-title":"Left atrial appendage obliteration: mechanisms of healing and intracardiac integration","volume":"3","author":"Schwartz","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.09.066_bb0240","doi-asserted-by":"crossref","first-page":"6704031","DOI":"10.1155\/2019\/6704031","article-title":"Left atrial appendage occlusion in high bleeding risk patients","volume":"2019","author":"Merella","year":"2019","journal-title":"J. Interv. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2022.09.066_bb0245","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"7","key":"10.1016\/j.ijcard.2022.09.066_bb0250","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/europace\/euaa074","article-title":"EWOLUTION Investigators. Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN","volume":"22","author":"Ledwoch","year":"2020","journal-title":"Europace."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322014164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322014164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T06:48:56Z","timestamp":1729320536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322014164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":50,"alternative-id":["S0167527322014164"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.09.066","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.09.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}